Zobrazeno 1 - 10
of 68
pro vyhledávání: '"J M, García García"'
Autor:
S. Koirala, S. Borisov, E. Danila, A. Mariandyshev, B. Shrestha, N. Lukhele, M. Dalcolmo, S.R. Shakya, S. Miliauskas, L. Kuksa, S. Manga, A. Aleksa, J.T. Denholm, H.B. Khadka, A. Skrahina, S. Diktanas, M. Ferrarese, J. Bruchfeld, A. Koleva, A. Piubello, G.S. Koirala, Z.F. Udwadia, D.J. Palmero, M. Munoz-Torrico, R. GC, G. Gualano, V.I. Grecu, I. Motta, A. Papavasileiou, Y. Li, W. Hoefsloot, H. Kunst, J. Mazza-Stalder, M.-C. Payen, O.W. Akkerman, E. Bernal, V. Manfrin, A. Matteelli, H. Mustafa Hamdan, M. Nieto Marcos, J. Cadiñanos Loidi, J.J. Cebrian Gallardo, R. Duarte, N. Escobar Salinas, R. Gomez Rosso, R. Laniado-Laborín, E. Martínez Robles, S. Quirós Fernandez, A. Rendon, I. Solovic, M. Tadolini, P. Viggiani, E. Belilovski, M.J. Boeree, Q. Cai, E. Davidavičienė, L.D. Forsman, J. De Los Rios, J. Drakšienė, A. Duga, S.E. Elamin, A. Filippov, A. Garcia, I. Gaudiesiute, B. Gavazova, R. Gayoso, V. Gruslys, J. Jonsson, E. Khimova, G. Madonsela, C. Magis-Escurra, V. Marchese, M. Matei, C. Moschos, B. Nakčerienė, L. Nicod, F. Palmieri, A. Pontarelli, A. Šmite, M.B. Souleymane, M. Vescovo, R. Zablockis, D. Zhurkin, J.-W. Alffenaar, J.A. Caminero, L.R. Codecasa, J.-M. García-García, S. Esposito, L. Saderi, A. Spanevello, D. Visca, S. Tiberi, E. Pontali, R. Centis, L. D'Ambrosio, M. van den Boom, G. Sotgiu, G.B. Migliori
Publikováno v:
Pulmonology, Vol 27, Iss 5, Pp 403-412 (2021)
The World Health Organization (WHO) recommends countries introduce new anti-TB drugs in the treatment of multidrug-resistant tuberculosis.The aim of the study is to prospectively evaluate the effectiveness of bedaquiline (and/or delamanid)- containin
Externí odkaz:
https://doaj.org/article/79e172ec72c9400c9c19243af6bbaddf
Autor:
I. Motta, R. Centis, L. D’Ambrosio, J.-M. García-García, D. Goletti, G. Gualano, F. Lipani, F. Palmieri, A. Sánchez-Montalvá, E. Pontali, G. Sotgiu, A. Spanevello, C. Stochino, E. Tabernero, M. Tadolini, M. van den Boom, S. Villa, D. Visca, G.B. Migliori
Publikováno v:
Pulmonology, Vol 26, Iss 4, Pp 233-240 (2020)
Little is known about the relationship between the COVID-19 and tuberculosis (TB). The aim of this study is to describe a group of patients who died with TB (active disease or sequelae) and COVID-19 in two cohorts.Data from 49 consecutive cases in 8
Externí odkaz:
https://doaj.org/article/98dd21f79d994f86970c1e24085dc434
Autor:
E, Tabernero, T, Rodrigo, J, Garros, L, Altube, E, Garay, J-F, Medina, J, Rodríguez, N, Ortiz, J-A, Gullón, J-M, García-García
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 26:842-849
BACKGROUND: TB in low-incidence countries is characterised by changes in age distribution towards larger numbers of cases among the elderly.OBJECTIVES: To investigate clinical features and outcomes of TB treatment in older patients and identify predi
Autor:
O. W. Akkerman, R. Duarte, S. Tiberi, H. S. Schaaf, C. Lange, J. W. C. Alffenaar, J. Denholm, A. C. C. Carvalho, M. S. Bolhuis, S. Borisov, J. Bruchfeld, A. M. Cabibbe, J. A. Caminero, I. Carvalho, J. Chakaya, R. Centis, M. P. Dalcomo, L. D´Ambrosio, M. Dedicoat, K. Dheda, K. E. Dooley, J. Furin, J-M. García-García, N. A. H. van Hest, B. C. de Jong, X. Kurhasani, A. G. Märtson, S. Mpagama, M. Munoz Torrico, E. Nunes, C. W. M. Ong, D. J. Palmero, R. Ruslami, A. M. I. Saktiawati, C. Semuto, D. R. Silva, R. Singla, I. Solovic, S. Srivastava, J. E. M. de Steenwinkel, A. Story, M. G. G. Sturkenboom, M. Tadolini, Z. F. Udwadia, A. R. Verhage, J. P. Zellweger, G. B. Migliori
Publikováno v:
International Journal of Tuberculosis and Lung Disease, 26(7), 592-604. International Union Against Tuberculosis and Lung Disease (The Union)
International Journal of Tuberculosis and Lung Disease, 26(7), 592-604. International Union against Tubercul. and Lung Dis.
International Journal of Tuberculosis and Lung Disease, 26(7), 592-604. International Union against Tubercul. and Lung Dis.
BACKGROUND: The aim of these clinical standards is to provide guidance on ‘best practice´ for diagnosis, treatment and management of drug-susceptible pulmonary TB (PTB).METHODS: A panel of 54 global experts in the field of TB care, public health,
Autor:
L R Codecasa, Dina Visca, M P Dalcolmo, Greg J. Fox, N Ambrosino, Anthony Byrne, Payam Nahid, M Vitacca, H S Schaaf, Andrea Rachow, C C Leung, Domingo Palmero, R C Teixeira, S Datta, Onno W. Akkerman, Zarir F Udwadia, Anna Cristina Calçada Carvalho, E Pontali, Rosella Centis, Graeme Hoddinott, R Singla, G Günther, Andre F.S. Amaral, R S Wallis, Jeremiah Chakaya, Christoph Lange, M. M. van der Zalm, Sophie Huddart, Simon Tiberi, A-T Dinh-Xuan, F. C.Q. Mello, J-M García-García, Denise Rossato Silva, L D Ambrosio, Rafael Laniado-Laborín, Kevin Mortimer, Florian M. Marx, Giovanni Sotgiu, Brian W. Allwood, M Muñoz-Torrico, Barbara Seaworth, Giovanni Battista Migliori, Carlton A. Evans, S Manga, Jennifer Furin, F Al Yaquobi, Catherine W.M. Ong, Raquel Duarte, S G Mpagama, Olena Ivanova, Antonio Spanevello, Ben J. Marais, D Chesov, Jose A. Caminero, Katerina Manika, Sergey Borisov, E Zampogna, Alberto Piubello, A Mariandyshev
Publikováno v:
International Journal of Tuberculosis and Lung Disease, 25(10), 797-813. International Union against Tubercul. and Lung Dis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol 25, iss 10
Int J Tuberc Lung Dis
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol 25, iss 10
Int J Tuberc Lung Dis
BACKGROUND: Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to provide guidance on the assessment and management of PTLD and the implementation of pulmon
Autor:
T Rodrigo, M Casals, J A Caminero, J M García-García, M A Jiménez-Fuentes, J F Medina, J P Millet, J Ruiz-Manzano, J Caylá, Working Group of the Integrated Programme of Tuberculosis Research
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0159925 (2016)
To determine the case-fatality rate (CFR) at the end of the intensive phase of tuberculosis (TB) treatment, and factors associated with fatality.TB patients diagnosed between 2006 and 2013 were followed-up during treatment. We computed the CFR at the
Externí odkaz:
https://doaj.org/article/c8be39b5e2b647a6b39fbc4c819a387f
Autor:
J.-A. Gullón-Blanco, T. Rodrigo-Sanz, F. Álvarez-Navascues, E. Tabernero-Huguet, J. Sabría-Mestres, J.-M. García-García, null and Integrated Tuberculosis Research Program
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 25:321-323
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
P, Rodríguez-Jiménez, I, Mir-Viladrich, P, Chicharro, G, Solano-López, F J, López-Longo, C, Taxonera, P, Sánchez-Martínez, X, Martínez-Lacasa, M, García-Gasalla, J, Dorca, M, Arias-Guillén, J M, García-García, E, Dauden
Publikováno v:
Actas dermo-sifiliograficas. 109(7)
Patients with chronic inflammatory diseases being treated with immunosuppressive drugs, and with tumor necrosis factor inhibitors in particular, have an increased risk of infection by Mycobacterium tuberculosis. Screening for latent tuberculosis infe